Janus Henderson Group PLC Soma Logic, Inc. Transaction History

Janus Henderson Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $209 - $336	-119 Reduced 0.18%	64,395 $162,000
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $9 - $12	5 Added 0.01%	64,514 $154,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $3.36 $3.51 Million - $5.62 Million	-1,673,305 Reduced 96.29%	64,509 $149,000
Q1 2023 May 15, 2023	SELL	$2.13 - $3.6 $9.07 Million - $15.3 Million	-4,257,817 Reduced 71.02%	1,737,814 $4.43 Million
Q4 2022 Feb 14, 2023	SELL	$2.05 - $3.47 $730,835 - $1.24 Million	-356,505 Reduced 5.61%	5,995,631 $15 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $1.69 Million - $14.7 Million	2,680,468 Added 73.0%	6,352,136 $18.4 Million
Q2 2022 Aug 15, 2022	BUY	$4.27 - $8.26 $142,852 - $276,338	33,455 Added 0.92%	3,671,668 $16.6 Million
Q1 2022 May 16, 2022	SELL	$7.07 - $11.62 $467,164 - $767,814	-66,077 Reduced 1.78%	3,638,213 $29.2 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $26.4 Million - $35.9 Million	2,516,303 Added 211.81%	3,704,290 $43.1 Million
Q3 2021 Nov 16, 2021	BUY	$9.94 - $12.77 $11.8 Million - $15.2 Million	1,187,987 New	1,187,987 $14.7 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.